View in EDS

The effects of next generation probiotics on metabolic dysfunction-associated steatotic liver disease: a parallel, double-blind, randomized, placebo-controlled trial.

Saved in:
Bibliographic Details
Title: The effects of next generation probiotics on metabolic dysfunction-associated steatotic liver disease: a parallel, double-blind, randomized, placebo-controlled trial.
Authors: Won SM; Institute for Liver and Digestive Diseases, Hallym University College of Medicine, Chuncheon, Republic of Korea., Joung H; Chong Kun Dang Bio Research Institute, Ansan-si, Gyeonggi-do, Republic of Korea., Park IG; Institute for Liver and Digestive Diseases, Hallym University College of Medicine, Chuncheon, Republic of Korea., Han SH; Department of Pathology, College of Medicine, Hallym University, Chuncheon, Republic of Korea., Ham YL; Department of Nursing, Daewon University College, Jecheon, Republic of Korea., Han JS; Institute for Liver and Digestive Diseases, Hallym University College of Medicine, Chuncheon, Republic of Korea., Kwon Y; Chong Kun Dang Bio Research Institute, Ansan-si, Gyeonggi-do, Republic of Korea., Kim DJ; Institute for Liver and Digestive Diseases, Hallym University College of Medicine, Chuncheon, Republic of Korea., Suk KT; Institute for Liver and Digestive Diseases, Hallym University College of Medicine, Chuncheon, Republic of Korea. ktsuk@hallym.ac.kr.
Source: Journal of translational medicine [J Transl Med] 2025 Dec 09; Vol. 24 (1), pp. 61. Date of Electronic Publication: 2025 Dec 09.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1479-5876
DOI:10.1186/s12967-025-07478-z